Could a special mesh stop hernias after colostomy?
NCT ID NCT02121743
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial investigates whether placing a biological mesh (Strattice) during colostomy creation can prevent parastomal hernia, a common complication. About 81 adults undergoing colorectal surgery with a terminal colostomy will be randomly assigned to receive the mesh or standard care. The study tracks hernia occurrence, pain, and surgical complications over two years.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Strattice (biological mesh)
- What this could lead to
- If effective, this mesh could become a standard way to prevent parastomal hernia after colostomy, reducing the need for additional surgeries.
- What could go wrong
- This is a relatively small study (81 participants) and results may not apply to all patients. The mesh could cause infection or other complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
81 people
The number who actually took part.
- Started
-
Apr 2014
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient requiring a colorectal surgery with a terminal colostomy * Elective or emergency surgery Exclusion Criteria: * Has collagen-vascular, connective tissue, or uncorrectable bleeding disorders as determined clinically by the PI. * Has any disease, including uncontrolled diabetes, which is clinically known to impact wound healing ability. * Has an autoimmune disease, an immune deficiency, or is on immune suppression drugs * Is pregnant, or lactating. * Allergic to any porcine or collagen products. * survival \< 6 months
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Parastomal hernia are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Amiens Universitary Hospital
Amiens, France
-
Amiens university hospital
Amiens, France
-
Beauvais hospital
Beauvais, France
-
Caen hospital
Caen, France
-
Charles Nicolle Hospital
Rouen, France
-
Claude Huriet Hospital
Lille, France
-
Lariboisiere Hospital
Paris, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A stitch in time: could a simple suture change cut colostomy hernia risk in half?
- Can we predict mesh infections before they happen? a new study aims to find out
- New keyhole surgery aims to fix stoma hernias with fewer comebacks
- Mesh may stop hernias after colostomy
- Hernia surgery study measures Body's inner pressure